Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002250:Carbon Radioisotopes; D002746:Chlorpromazine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002794:Choline / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006426:Hemicholinium 3 / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D001679:Biogenic Amines; D002250:Carbon Radioisotopes; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D006426:Hemicholinium 3; D012701:Serotonin; D001285:Atropine; D010293:Pargyline; D010830:Physostigmine; D014446:Tyrosine 3-Monooxygenase; D002794:Choline; D000109:Acetylcholine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine